News and Reports
 
  - 
  Nabriva Therapeutics raises Euro 15 million (USD 22 million)28 October 2009Download
- 
  Asthmatx receives FDA advisory panel recommendation for 'approvable with conditions' for bronchial thermoplasty with the Alair system for severe Asthma28 October 2009Download
- 
  PTC Therapeutics initiates phase 2 clinical trial of Ataluren (PTC124) in patients with Hemophilia26 October 2009Download
- 
  Lux Biosciences's potential of LUVENIQ (LX211) as first disease modifying treatment for sight-threatening non-infectious Uveitis highlighted at American Academy of Ophthalmology26 October 2009Download
- 
  Lux Biosciences completes $50 million series B financing19 October 2009Download
- 
  Paratek Pharmaceuticals signs worldwide license and commercialization agreement for PTK 0796, broad-spectrum oral and IV antibiotic in phase 38 October 2009Download
- 
  mtm laboratories extends series C financing round by EUR 7 million bringing total to EUR 39 million (USD 57 million)5 October 2009Download
- 
  Sloning closes growth financing round led by LBBW Venture25 September 2009Download
- 
  Mpex Pharmaceuticals announces positive phase 2b clinical trial results with Aeroquin (MP-376) treatment in Cystic Fibrosis patients20 September 2009Download
- 
  HBM Partners successful trade sale of Swiss biotech company ESBATech to Alcon14 September 2009Download
- 
  PTC Therapeutics initiates registration-directed Phase 3 trial of Ataluren in Cystic Fibrosis10 September 2009Download
- 
  MiCardia announces completion of enrollment in “DYANA” European CE study4 September 2009Download
- 
  Successful sale of BRAHMS in an all-cash transaction to Thermo Fisher Scientific: Net profit for HBM advised antities of EUR 134.2 million, or 21.6 times the invested equity3 September 2009Download
- 
  PTC Therapeutics announces achievement of major milestone in Schering- Plough Hepatitis C collaboration10 August 2009Download
- 
  Zosana Pharma, Inc. secures $30 million in new round of financing7 July 2009Download
- 
  Brahms - New cardiac marker copeptin accelerates diagnosis of acute myocardial infarction (AMI)2 July 2009Download
- 
  Sloning BioTechnology and Henkel to cooperate in enzyme development30 June 2009Download
- 
  Brahms - Cezanne and Lumiphore announces partnership for diagnostic tests22 June 2009Download
- 
  Vivacta raises $4.5 million to commercialise piezofilm technology16 June 2009Download
- 
  MiCardia announces first U.S. implant16 June 2009Download
- 
  Devax receives IDE approval to commence bifurcation stent trial29 May 2009Download
- 
  mtm laboratories and MetaSystems agree on partnership to develop Automated CINtec Cytology Imaging System26 May 2009Download
- 
  Brahms - for the first time, a new Biomarker test enables detection of Alzheimer's dementia in blood15 May 2009Download
- 
  Diagnostics company BRAHMS presents positive results for 200813 May 2009Download
- 
  Merck KGaA, global partner of Newron, initiates second phase III trial of safinamide in advanced Parkinson's disease7 May 2009Download